Pharmacogenomics Company Develops Innovative Test

While in San Diego, Advocacy staff visited a small innovative medical technology company called AltheaDx to meet with their CEO, Greg Hamilton. AltheaDx offers a genetic test and report, recently introduced to the market, that provides patients and healthcare providers a series of recommendations fo...

Full description

Saved in:
Bibliographic Details
Published in:The Small Business Advocate 2015-09, Vol.34 (7), p.4
Main Author: Rostker, David
Format: Article
Language:English
Subjects:
Cardiovascular disease
Cost control
Cost reduction
Medical technology
Migraine
Neurological disorders
Pain
Patients
Pharmaceutical industry
R&D
Research & development
Small business
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 7
container_start_page 4
container_title The Small Business Advocate
container_volume 34
creator Rostker, David
description While in San Diego, Advocacy staff visited a small innovative medical technology company called AltheaDx to meet with their CEO, Greg Hamilton. AltheaDx offers a genetic test and report, recently introduced to the market, that provides patients and healthcare providers a series of recommendations for the pharmaceutical treatment of pain, cardiovascular disease and psycho-neurological disorders. This relatively new but rapidly growing field of medicine, called pharmacogenomics, has the potential to significantly reduce drug costs and improve the quality of care, particularly as drug costs continue to outpace inflation and the population ages.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_1723793530</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3841245401</sourcerecordid><originalsourceid>FETCH-proquest_reports_17237935303</originalsourceid><addsrcrecordid>eNpjYeA0NDAx1TU3M7XgYOAqLs4yMDAzMrCw4GQwDMhILMpNTM5PT83Lz81MLlZwzs8tSMyrVHBJLUvNyS8oVvDMy8svSyzJLEtVCEktLuFhYE1LzClO5YXS3AxKbq4hzh66BUX5haVABfFFqQX5RSXF8YbmRsbmlsamxgbGRCkCAA84MpY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1723793530</pqid></control><display><type>article</type><title>Pharmacogenomics Company Develops Innovative Test</title><source>EBSCOHost: Business Source Ultimate</source><creator>Rostker, David</creator><creatorcontrib>Rostker, David</creatorcontrib><description>While in San Diego, Advocacy staff visited a small innovative medical technology company called AltheaDx to meet with their CEO, Greg Hamilton. AltheaDx offers a genetic test and report, recently introduced to the market, that provides patients and healthcare providers a series of recommendations for the pharmaceutical treatment of pain, cardiovascular disease and psycho-neurological disorders. This relatively new but rapidly growing field of medicine, called pharmacogenomics, has the potential to significantly reduce drug costs and improve the quality of care, particularly as drug costs continue to outpace inflation and the population ages.</description><identifier>ISSN: 1045-7658</identifier><language>eng</language><publisher>Washington: Small Business Administration</publisher><subject>Cardiovascular disease ; Cost control ; Cost reduction ; Medical technology ; Migraine ; Neurological disorders ; Pain ; Patients ; Pharmaceutical industry ; R&amp;D ; Research &amp; development ; Small business</subject><ispartof>The Small Business Advocate, 2015-09, Vol.34 (7), p.4</ispartof><rights>Copyright US Small Business Administration Sep/Oct 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,776,780,787</link.rule.ids></links><search><creatorcontrib>Rostker, David</creatorcontrib><title>Pharmacogenomics Company Develops Innovative Test</title><title>The Small Business Advocate</title><description>While in San Diego, Advocacy staff visited a small innovative medical technology company called AltheaDx to meet with their CEO, Greg Hamilton. AltheaDx offers a genetic test and report, recently introduced to the market, that provides patients and healthcare providers a series of recommendations for the pharmaceutical treatment of pain, cardiovascular disease and psycho-neurological disorders. This relatively new but rapidly growing field of medicine, called pharmacogenomics, has the potential to significantly reduce drug costs and improve the quality of care, particularly as drug costs continue to outpace inflation and the population ages.</description><subject>Cardiovascular disease</subject><subject>Cost control</subject><subject>Cost reduction</subject><subject>Medical technology</subject><subject>Migraine</subject><subject>Neurological disorders</subject><subject>Pain</subject><subject>Patients</subject><subject>Pharmaceutical industry</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Small business</subject><issn>1045-7658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpjYeA0NDAx1TU3M7XgYOAqLs4yMDAzMrCw4GQwDMhILMpNTM5PT83Lz81MLlZwzs8tSMyrVHBJLUvNyS8oVvDMy8svSyzJLEtVCEktLuFhYE1LzClO5YXS3AxKbq4hzh66BUX5haVABfFFqQX5RSXF8YbmRsbmlsamxgbGRCkCAA84MpY</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Rostker, David</creator><general>Small Business Administration</general><scope>3V.</scope><scope>4S-</scope><scope>4T-</scope><scope>7X5</scope><scope>7XB</scope><scope>8A3</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K60</scope><scope>K6~</scope><scope>L.-</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20150901</creationdate><title>Pharmacogenomics Company Develops Innovative Test</title><author>Rostker, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_17237935303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cardiovascular disease</topic><topic>Cost control</topic><topic>Cost reduction</topic><topic>Medical technology</topic><topic>Migraine</topic><topic>Neurological disorders</topic><topic>Pain</topic><topic>Patients</topic><topic>Pharmaceutical industry</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Small business</topic><toplevel>online_resources</toplevel><creatorcontrib>Rostker, David</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>BPIR.com Limited</collection><collection>Docstoc</collection><collection>ProQuest Entrepreneurship</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Entrepreneurship Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Business Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>Proquest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>The Small Business Advocate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rostker, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenomics Company Develops Innovative Test</atitle><jtitle>The Small Business Advocate</jtitle><date>2015-09-01</date><risdate>2015</risdate><volume>34</volume><issue>7</issue><spage>4</spage><pages>4-</pages><issn>1045-7658</issn><abstract>While in San Diego, Advocacy staff visited a small innovative medical technology company called AltheaDx to meet with their CEO, Greg Hamilton. AltheaDx offers a genetic test and report, recently introduced to the market, that provides patients and healthcare providers a series of recommendations for the pharmaceutical treatment of pain, cardiovascular disease and psycho-neurological disorders. This relatively new but rapidly growing field of medicine, called pharmacogenomics, has the potential to significantly reduce drug costs and improve the quality of care, particularly as drug costs continue to outpace inflation and the population ages.</abstract><cop>Washington</cop><pub>Small Business Administration</pub></addata></record>
fulltext fulltext
identifier ISSN: 1045-7658
ispartof The Small Business Advocate, 2015-09, Vol.34 (7), p.4
issn 1045-7658
language eng
recordid cdi_proquest_reports_1723793530
source EBSCOHost: Business Source Ultimate
subjects Cardiovascular disease
Cost control
Cost reduction
Medical technology
Migraine
Neurological disorders
Pain
Patients
Pharmaceutical industry
R&D
Research & development
Small business
title Pharmacogenomics Company Develops Innovative Test
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T20%3A50%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenomics%20Company%20Develops%20Innovative%20Test&rft.jtitle=The%20Small%20Business%20Advocate&rft.au=Rostker,%20David&rft.date=2015-09-01&rft.volume=34&rft.issue=7&rft.spage=4&rft.pages=4-&rft.issn=1045-7658&rft_id=info:doi/&rft_dat=%3Cproquest%3E3841245401%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_reports_17237935303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1723793530&rft_id=info:pmid/&rfr_iscdi=true